LTFS
ESPR

Ladenburg Thalmann Financial Services’s Esperion Therapeutics ESPR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$80K Buy
1,348
+546
+68% +$24.5K ﹤0.01% 3178
2019
Q3 		$30K Sell
802
-25
-3% -$990 ﹤0.01% 3773
2019
Q2 		$38K Hold
827
– – ﹤0.01% 3635
2019
Q1 		$33K Sell
827
-220
-21% -$9.87K ﹤0.01% 3682
2018
Q4 		$48K Buy
1,047
+814
+349% +$39.2K ﹤0.01% 3272
2018
Q3 		$11K Sell
233
-782
-77% -$35.9K ﹤0.01% 4226
2018
Q2 		$74K Hold
1,015
– – ﹤0.01% 2975
2018
Q1 		$74K Sell
1,015
-509
-33% -$37.4K ﹤0.01% 2975
2017
Q4 		$101K Sell
1,524
-40
-3% -$2.15K ﹤0.01% 2711
2017
Q3 		$79K Buy
1,564
+514
+49% +$24.8K ﹤0.01% 2753
2017
Q2 		$49K Buy
1,050
+164
+19% +$6.03K ﹤0.01% 3034
2017
Q1 		$31K Sell
886
-14
-2% -$321 ﹤0.01% 3246
2016
Q4 		$11K Hold
900
– – ﹤0.01% 3812
2016
Q3 		$12K Hold
900
– – ﹤0.01% 3706
2016
Q2 		$9K Hold
900
– – ﹤0.01% 3830
2016
Q1 		$15K Hold
900
– – ﹤0.01% 3442
2015
Q4 		$20K Buy
+900
New +$22.7K ﹤0.01% 3219

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ESPR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Esperion Therapeutics (ESPR) stake by 68% in Q4 2019, buying an estimated $24.5K and bringing the position to 1,348 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #3178.

Ladenburg Thalmann Financial Services first reported a position in ESPR in Q4 2015 and has held it in 17 quarters since. The position peaked at $101K in Q4 2017. 172 funds tracked by Wall St. Rank hold ESPR as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,348 shares of Esperion Therapeutics worth $80K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 546 Esperion Therapeutics shares in Q4 2019, an estimated $24.5K.
  • Esperion Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3178 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Esperion Therapeutics in Q4 2015 and has held it in 17 quarters since.
  • Ladenburg Thalmann Financial Services's Esperion Therapeutics position peaked at $101K in Q4 2017.
  • 172 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.